Novel MRI agent details early breast cancer September 26, 2017 -- Researchers at Case Western Reserve University are reporting early success with an MRI contrast agent that detects early-stage breast cancer and the disease's degree of aggression. Results were published online September 25 in Nature Communications.
ACR sounds alarm regarding CMS' site-neutral policy September 26, 2017 -- The American College of Radiology (ACR) met with Trump administration appointees to the U.S. Centers for Medicare and Medicaid Services (CMS) and the Office of Management and Budget to express concern about policies that could threaten implementation of clinical decision support and lead to further cuts to radiology reimbursement.
ASTRO: Short radiation course safe for breast cancer September 26, 2017 -- A shorter-course, higher-dose protocol for breast cancer radiation therapy is safe for patients younger than 50, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego.
Strategic Radiology radiologists to work on Watson September 26, 2017 -- Thirty radiologists from radiology consortium Strategic Radiology will work on the Watson Health Medical Imaging Collaborative to advance natural language processing capabilities used in future cognitive medical imaging technologies.
FDA clears Abbott's ICD for use with MRI September 25, 2017 -- Abbott Laboratories has received clearance from the U.S. Food and Drug Administration (FDA) for its Ellipse implantable cardioverter defibrillator (ICD) with MRI-conditional labeling.
Rad Technology unveils Healing Portals September 25, 2017 -- Rad Technology Medical Systems unveiled its Healing Portals images at the annual American Society for Radiation Oncology meeting in San Diego.
Mirada's deep-learning contours match human-drawn contours September 25, 2017 -- Imaging software developer Mirada Medical revealed during the American Society for Radiation Oncology (ASTRO) annual meeting that contours drawn using its deep-learning software are mostly indistinguishable from human-drawn contours.
IBA, Elekta join forces on software development September 25, 2017 -- Proton therapy firm Ion Beam Applications (IBA) and radiation oncology vendor Elekta have entered into a memorandum of understanding to work together in software development as well as the sales and marketing of each other's products.